New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
08:32 EDTEXARExar signs distribution agreement with Setron
Exar announced it has signed a distribution agreement with Setron, a central European components distributor.
News For EXAR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 13, 2015
09:21 EDTEXARExar takeout possible at $12-$13 per share, says Cowen
Cowen noted Exar is exploring strategic alternatives and believes a company sale could result in the $12-$13 range. The firm also thinks Exar could decide to shed its data compression business and build analog/mixed signal scale. Cowen has an Outperform rating and $13 price target on Exar.
May 12, 2015
16:14 EDTEXARExar to undertake comprehensive review of strategic alternatives
Exar announced that its Board of Directors has unanimously decided to undertake a comprehensive review of strategic alternatives to enhance value for stockholders. Exar intends to conduct a thorough review and evaluation of strategic alternatives. Cowen and Company, LLC is acting as financial advisor, and O'Melveny & Myers LLP is acting as legal counsel, to Exar in connection with its review of strategic alternatives. "Following a detailed evaluation over the past several months, our Board of Directors has determined that it is prudent to undertake a wide review of strategic options to see which alternatives provide the best means to maximize stockholder value," said Mr. DiNardo. "Regardless of the outcome of the strategic alternatives review, the entire Exar team remains fully committed to meeting the needs of our customers and continuing to provide industry-leading solutions."
16:13 EDTEXARExar sees Q1 EPS 10c-12c, consensus 12c
Subscribe for More Information
16:11 EDTEXARExar reports Q4 EPS 11c, consensus 11c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use